Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021)
- Authors:
- USP affiliated authors: GOMES, CLAUDIANA LAMEU - IQ ; ULRICH, ALEXANDER HENNING - IQ ; RIBEIRO, DEIDIANE ELISA - IQ ; GIACOMELLI, ÁGATHA OLIVEIRA - IQ ; GLASER, TALITA - IQ ; SAMPAIO, VANESSA FERNANDES ARNAUD - IQ ; BARANOVA, JULIANA - IQ
- Unidade: IQ
- DOI: 10.1038/s41380-020-00965-3
- Subjects: COVID-19; RECEPTORES; SURTOS DE DOENÇAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular Psychiatry
- ISSN: 1359-4184
- Volume/Número/Paginação/Ano: v. 26, p. 1044–1059, 2021
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
RIBEIRO, Deidiane Elisa et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, v. 26, p. 1044–1059, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41380-020-00965-3. Acesso em: 08 abr. 2026. -
APA
Ribeiro, D. E., Giacomelli, Á. O., Glaser, T., Sampaio, V. F. A., Andrejew, R., Dieckmann, L., et al. (2021). Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, 26, 1044–1059. doi:10.1038/s41380-020-00965-3 -
NLM
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1038/s41380-020-00965-3 -
Vancouver
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1038/s41380-020-00965-3 - Calcium signalling: a common target in neurological disorders and neurogenesis
- Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease
- The P2X7 receptor: central hub of brain diseases
- Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]
- Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases
- Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases
- Stem cells: principles and applications
- ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research
- Cancer metabostemness and metabolic reprogramming via P2X7 receptor
- Complex diseases demand novel treatment strategies: understanding drug combination
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
